Skip to main content
Log in

Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values

  • Urogenital
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the influence of the choice of b values on the diagnostic value of the apparent diffusion coefficient (ADC) for detection and grading of prostate cancer (PCa).

Methods

Forty-one patients with biopsy-proven PCa underwent endorectal 3-T MRI before prostatectomy. Different combinations of b values (0–800 s/mm2) were used to calculate four representative ADC maps. Mean ADCs of tumours and non-malignant tissue were determined. Tumour appearance on different ADC maps was rated by three radiologists as good, fair or poor by assigning a visual score (VS) of 2, 1 or 0, respectively. Differences in the ADC values with the choice of b values were analysed using one-way ANOVA.

Results

Choice of b values had a highly (P < 0.001) significant influence on the absolute ADC in each tissue. Maps using b = [50, 800] and [0, 800] were rated best (VS = 1.6 ± 0.3) and second best (1.1 ± 0.3, P < 0.001), respectively. For low-grade carcinomas (Gleason score ≤ 6, 13/41 patients), only the former choice received scores better than fair (VS = 1.4 ± 0.3). Mean tumour ADCs showed significant negative correlation (Spearman’s ρ −0.38 to −0.46, P < 0.05) with Gleason score.

Conclusions

Absolute ADC values strongly depend on the choice of b values and therefore should be used with caution for diagnostic purposes. A minimum b value greater than zero is recommended for ADC calculation to improve the visual assessment of PCa in ADC maps.

Key Points

Absolute ADC values are highly dependent on the choice of b values.

Absolute ADC thresholds should be used carefully to predict tumour aggressiveness.

Subjective ratings of ADC maps involving b = 0 s/mm 2 are poor to fair.

Minimum b value greater than 0 s/mm 2 is recommended for ADC calculation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

CG:

central gland

CSI:

chemical shift imaging

GS:

Gleason score

PCa:

prostate cancer

PZ:

peripheral zone

VS:

visual score

References

  1. Dickinson L, Ahmed HU, Allen C et al (2011) Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59:477–494

    Article  PubMed  Google Scholar 

  2. Schlemmer H-P (2010) Multiparametric MRI of the prostate: method for early detection of prostate cancer? Rofo 182:1067–1075

    Article  PubMed  Google Scholar 

  3. Gibbs P, Tozer DJ, Liney GP, Turnbull LW (2001) Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 46:1054–1058

    Article  PubMed  CAS  Google Scholar 

  4. Turkbey B, Shah VP, Pang Y et al (2011) Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 258:488–495

    Article  PubMed  Google Scholar 

  5. Hambrock T, Somford DM, Huisman HJ et al (2011) Relationship between apparent diffusion coefficients at 3.0-T MR imaging and gleason grade in peripheral zone prostate cancer. Radiology 259:453–461

    Article  PubMed  Google Scholar 

  6. Kim CK, Park BK, Lee HM, Kwon GY (2007) Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3-T using a phased-array coil: preliminary results. Invest Radiol 42:842–847

    Article  PubMed  Google Scholar 

  7. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S (2007) Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 25:146–152

    Article  PubMed  Google Scholar 

  8. Haider MA, van der Kwast TH et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323–328

    Article  PubMed  Google Scholar 

  9. Tamada T, Sone T, Jo Y et al (2008) Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 28:720–726

    Article  PubMed  Google Scholar 

  10. Gibbs P, Pickles MD, Turnbull LW (2006) Diffusion imaging of the prostate at 3.0 Tesla. Invest Radiol 41:185–188

    Article  PubMed  Google Scholar 

  11. Lim HK, Kim JK, Kim KA, Cho K-S (2009) Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection – a multireader study. Radiology 250:145–151

    Article  PubMed  Google Scholar 

  12. Riches SF, Hawtin K, Charles-Edwards EM, de Souza NM (2009) Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients. NMR Biomed 22:318–325

    Article  PubMed  CAS  Google Scholar 

  13. Shinmoto H, Oshio K, Tanimoto A et al (2009) Biexponential apparent diffusion coefficients in prostate cancer. Magn Reson Imaging 27:355–359

    Article  PubMed  Google Scholar 

  14. Kitajima K, Kaji Y, Kuroda K, Sugimura K (2008) High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci 7:93–99

    Article  PubMed  Google Scholar 

  15. Kim CK, Park BK, Kim B (2010) High-b-value diffusion-weighted imaging at 3-T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol 194:W33–37

    Article  PubMed  Google Scholar 

  16. Verma S, Rajesh A, Fütterer JJ et al (2010) Prostate MRI and 3D MR spectroscopy: how we do it. AJR Am J Roentgenol 194:1414–1426

    Article  PubMed  Google Scholar 

  17. D’Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen M-H (2003) Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 21:2163–2172

    Article  PubMed  Google Scholar 

  18. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505

    PubMed  Google Scholar 

  19. DeLano MC, Cooper TG, Siebert JE, Potchen MJ, Kuppusamy K (2000) High-b-value diffusion-weighted MR imaging of adult brain: image contrast and apparent diffusion coefficient map features. AJNR Am J Neuroradiol 21:1830–1836

    PubMed  CAS  Google Scholar 

  20. Gleason DF (1992) Histologic grading of prostate cancer: a perspective. Hum Pathol 23:273–279

    Article  PubMed  CAS  Google Scholar 

  21. Uhl M, Altehoefer C, Kontny U, Il'yasov K, Büchert M, Langer M (2002) MRI-diffusion imaging of neuroblastomas: first results and correlation to histology. Eur Radiol 12:2335–2338

    PubMed  CAS  Google Scholar 

  22. Vargas HA, Akin O, Franiel T et al (2011) Diffusion-weighted endorectal MR imaging at 3-T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 259:775–784

    Article  PubMed  Google Scholar 

  23. Maier SE, Tang Y, Panych LP, Mulkern RV, Tempany CM (2011) Non-monoexponential diffusion signal decay in prostate cancer. Proc. of 19th ISMRM Annual Meeting and Exhibition, Montreal

  24. Hom JJ, Coakley FV, Simko JP et al (2006) Prostate cancer: endorectal MR imaging and MR spectroscopic imaging – distinction of true-positive results from chance-detected lesions. Radiology 238:192–199

    Article  PubMed  Google Scholar 

  25. Vilanova JC, Comet J, Barceló-Vidal C et al (2009) Peripheral zone prostate cancer in patients with elevated PSA levels and low free-to-total PSA ratio: detection with MR imaging and MR spectroscopy. Radiology 253:135–143

    Article  PubMed  Google Scholar 

  26. Kim JH, Kim JK, Park B-W, Kim N, Cho K-S (2008) Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region. J Magn Reson Imaging 28:1173–1179

    Article  PubMed  Google Scholar 

  27. Mazaheri Y, Hricak H, Fine SW et al (2009) Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 252:449–457

    Article  PubMed  Google Scholar 

  28. Park SY, Kim CK, Park BK, Lee HM, Lee KS (2011) Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results. Eur Radiol 21:1111–1118

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

Grant support from the German Federal Ministry of Education and Research under BMBF 13N10360 is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harald Busse.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thörmer, G., Otto, J., Reiss-Zimmermann, M. et al. Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values. Eur Radiol 22, 1820–1828 (2012). https://doi.org/10.1007/s00330-012-2432-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-012-2432-3

Keywords

Navigation